Clinical Trial Update: Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy and safety results for SYR-472 in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SYR-472

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED